Peter Wolfe

Chief Financial Officer, ZyVersa Therapeutics, Inc.

Companies

ZyVersa Therapeutics, Inc.Chief financial officer Dec 13, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ZyVersa Therapeutics, Inc. ZVSA44,585 shares²$2.1K at $0.05Dec 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 16, 2022Granted 3,000 shares at $2.88 of ZyVersa Therapeutics, Inc.²
Dec 12, 2022Granted 41,585 shares of ZyVersa Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARZyVersa Therapeutics, Inc., Chief financial officer
2
SEC EDGARZyVersa Therapeutics, Inc. shares after the filing of Dec 16, 2022
3
SEC EDGARForm 4 filed Dec 14, 2022